Login / Signup

Which terms should be used to describe medications used in the treatment of seizure disorders? An ILAE position paper.

Emilio PeruccaJacqueline A FrenchGhaieb AljandeelSimona BalestriniPatricia BragaJorge G BurneoAugustina Charway FelliJudith Helen CrossAristea S GalanopoulouSatish JainYu-Wu JiangReetta KalviainenShih-Hui LimKimford J MeadorZarine MogalRima NabboutFrancesca SofiaErnest R SomervilleMickael R SperlingChahnez Charfi TrikiEugen TrinkaMatthew C WalkerSamuel WiebeJo M WilmshurstElaine C WirrellElza Marcia Targas YacubianJaideep Kapur
Published in: Epilepsia (2024)
A variety of terms, such as "antiepileptic," "anticonvulsant," and "antiseizure" have been historically applied to medications for the treatment of seizure disorders. Terminology is important because using terms that do not accurately reflect the action of specific treatments may result in a misunderstanding of their effects and inappropriate use. The present International League Against Epilepsy (ILAE) position paper used a Delphi approach to develop recommendations on English-language terminology applicable to pharmacological agents currently approved for treating seizure disorders. There was consensus that these medications should be collectively named "antiseizure medications". This term accurately reflects their primarily symptomatic effect against seizures and reduces the possibility of health care practitioners, patients, or caregivers having undue expectations or an incorrect understanding of the real action of these medications. The term "antiseizure" to describe these agents does not exclude the possibility of beneficial effects on the course of the disease and comorbidities that result from the downstream effects of seizures, whenever these beneficial effects can be explained solely by the suppression of seizure activity. It is acknowledged that other treatments, mostly under development, can exert direct favorable actions on the underlying disease or its progression, by having "antiepileptogenic" or "disease-modifying" effects. A more-refined terminology to describe precisely these actions needs to be developed.
Keyphrases
  • temporal lobe epilepsy
  • healthcare
  • end stage renal disease
  • preterm infants
  • primary care
  • chronic kidney disease
  • palliative care
  • autism spectrum disorder
  • clinical practice
  • replacement therapy
  • health information